New Investigator Award

AACP Resource

2023 Award Information

The 2022–2023 New Investigator Award cycle has launched. The Letter of Intent (LOI) submission portal closed on August 10, 2022. Letter of Intent decisions have been sent to all applicants. The 2023 NIA Application for all accepted LOI applicants is due September 16, 2022.


Sponsored by the American Association of Colleges of Pharmacy (AACP), the New Investigator Award provides start-up funding for the independent research programs of early-career pharmacy faculty. This grant is intended to be the first extramural research funding received by a faculty member as a principal investigator (PI), with the goal that research funded by the NIA will provide a foundation for future scholarly endeavors and continued extramural funding success. Each grant of $7,500 to $10,000 (no overhead allowed) will be awarded in March 2023. Intramural university or college/school start-up support may be used to supplement the proposed research.

An eligible applicant must have an earned terminal degree (Pharm.D., Ph.D., or equivalent) and have a regular full-time faculty appointment at the assistant professor level at a U.S. college or school of pharmacy that is accredited by ACPE (either candidate or full accreditation status). The applicant's institution must be a regular institutional member of AACP, and the applicant must also be a current individual member of AACP. The applicant’s initial appointment to a full-time faculty position, whether at a previous or the current institution, must not be earlier than July 1, 2017. A faculty member who has been a PI on an AACP NIA or equivalent starter grant, on a professional (e.g., ACCP, ASHP, AAPS, PhRMA, etc.), organizational (e.g., American Heart Association, American Cancer Association, American Brain Tumor Association, etc.) or federal grant (e.g., NIH, NSF, AHRQ, DOD, CDC, etc.) as a faculty member is not eligible to apply. Proposals from applicants who do not meet these eligibility criteria will not be reviewed.

Only one application per investigator will be accepted for review. Each applicant is required to identify a research mentor with whom to discuss and review the application before submission. Resubmission of previously unfunded NIA proposals is acceptable, and those applicants should include an additional page in their proposal in which to address previous reviewer comments.

Each recipient of the 2023 NIA will also receive a travel award from AACP to present the investigator's research findings at the 2023 AACP Annual Meeting.


Proposals from applicants who do not meet the individual eligibility criteria or who are, at the time of the application deadline, employed at institutions that do not meet the institutional eligibility criteria will not be reviewed.

Institutional Eligibility

  • Applications will only be accepted from applicants currently appointed at U.S. colleges and schools of pharmacy that are accredited by the Accreditation Council for Pharmacy Education (ACPE) at the Candidate or Accredited status. More information regarding accreditation status of institutions can be found on the ACPE website.

Individual Eligibility

  • An applicant for the NIA must be a current individual member of AACP to access the online submission portal. AACP individual membership application and renewal information is located on the AACP website.
  • Eligible applicants must have an earned terminal degree (Pharm.D., Ph.D. or equivalent);
  • At the time of application, an applicant must have a regular full-time faculty appointment at the assistant professor level at an eligible institution (see above);
  • An applicant's initial appointment to a full-time faculty position, whether at a previous or the current institution, must not be earlier than July 1, 2017; and
  • Applicants must not have received previous grant funding as a principal investigator on an AACP NIA or equivalent starter grant, on a professional (e.g., ACCP, ASHP, AAPS, PhRMA, etc.), organizational (e.g., American Heart Association, American Cancer Association, American Brain Tumor Association, etc.) or federal grant (e.g., NIH, NSF, AHRQ, DOD, CDC, etc.) once appointed to a faculty position. Previous funding from these types of sources while the applicant was still a student or postdoctoral trainee is acceptable.


NIA Application

  • An invitation to begin and submit a full NIA application on CadmiumCD platform has been sent to all accepted LOI applicants.

Submission of a Letter of Intent

A Letter of Intent (LOI) is required as part of the application process. The LOI is an online form used to gather demographic information and a 250-word abstract of the applicant’s proposed NIA research project that will enable the review committee to begin selecting qualified reviewers for each anticipated application. The LOI submission portal on CadmiumCD platform closed on August 10, 2022.

Guidelines for Selecting a Mentor (Up to 2)

The applicant is required to enlist a research mentor with whom to discuss the proposed project and preview the application. The mentor does not have to be faculty member at the applicant’s institution; however, the mentor must have sufficient time and scientific expertise in the proposed research topic in order to advise the applicant during the application period and as needed during the award period. The mentor’s signature is required on the Title Page, and a letter of support from the mentor is encouraged.

Choosing a Disciplinary Section

Applications will be peer reviewed by reviewers appointed by the AACP section immediate past chairs. The applicant must designate a section in the LOI to assist the NIA Review Committee in identifying appropriate peer reviewers. It is critical that applicants designate the appropriate section based on the nature of the proposed research in order to receive a fair and complete review. The following is offered as a guide for you to select the appropriate section:

  • Administrative Services: Administrative Effectiveness and Efficiency, Admission Practices, Student Development, Alumni and Community Relations, Novel Approaches to Organizational Leadership and Development, Policy, Governance, Analysis, Human Resources, Budget/Finance, Student Administration, Institutional and Community Relations
  • Biological Sciences: Animal Model Pharmacodynamics, Biotechnology/Molecular Biology, Pharmacology/Toxicology, Pharmacogenomics, Proteomics
  • Chemistry: Medicinal/Pharmaceutical/Analytical/Natural Products Chemistry, SAR Studies
  • Continuing Professional Development: Active Learning Strategies, Innovative CPD Programs
  • Experiential Education: Standardized Assessment, IPPE/APPE, Simulation
  • Drug Information and Library Science: Search Strategies for Scholarly Endeavors, Engaging Students in Library Resources
  • Pharmaceutics: Theoretical or Animal Pharmacokinetics, Biopharmaceutics, Drug Delivery/Formulation
  • Pharmacy Practice: Clinical Pharmacy, Clinical Pharmacokinetics, Clinical Drug Evaluation, Human Pharmacodynamics
  • Social and Administrative Sciences: Health Services Research, Human Social/Behavioral Studies, Pharmacoeconomics

If you are unsure of which Section to select in your LOI, please contact for assistance. During initial review of LOIs, section immediate past chairs may elect to move an application to a different section if it is determined that the scope of the proposal falls outside of the expertise of the originally selected section. If you believe you selected the incorrect section in your LOI, please contact immediately to make arrangements for your applicant to be moved to another section; please do not select a different section in your application without contacting before submitting your application, or your application may not be reviewed in a timely manner.

Submission of a Full Application

The NIA Application Form is to be completed according to the instructions provided on the 2023 New Investigator Award Application Instructions page below. The full application, consisting of six tasks, including the Research Narrative. This application form must be completed through the CadmiumCD submission portal by the deadline, September 16, 2022 at 11:59 PM EST. An application cannot be uploaded on to the submission portal until the applicant’s LOI has been reviewed and accepted by AACP staff in August. AACP staff will notify eligible applicants when full applications will be accepted in the submission portal. A proposal that is determined to be incomplete or does not meet the guidelines described above will be returned without review.

Required Signatures

The following persons are required to sign the NIA application/proposal with the acknowledgement that they have read and reviewed the proposal before submission:

  • The applicant/principal investigator (PI);
  • The applicant’s mentor (see below for more information); and
  • The applicant’s CEO dean.

NOTE: Electronic signatures will now be accepted in addition to original signatures. If original signatures are collected, please scan the Title Page with the required signatures to include in the application. The applicant’s college or school may safely keep the original signature page.

Review and Selection Process

The NIA Review Committee consists of the following individuals:

  • Council of Sections Immediate Past Chair (NIA Review Committee Chair)
  • Council of Sections Chair
  • Council of Sections Chair Elect
  • Immediate Past Chairs of all nine AACP Sections

Review of NIA proposals is conducted in two phases:

  • In Phase 1, proposals are sorted by AACP disciplinary section and reviewed by peers from within that section. More information to assist the applicant in choosing a section to which a proposal should be submitted can be found below. During this phase, attention will be given to the appropriateness of the objectives and methods to ensure that expectations are within the scope of the project and achievable within the one-year timeline of the NIA.
  • In Phase 2, top scoring proposals from across all of the sections are compared to each other using scores and reviewer comments from Phase 1. Final funding recommendations are made based on the overall scientific merit, with additional consideration given to the contribution of the proposed research to the applicant's career and alignment of the proposal with the strategic goals and mission of AACP. 

Announcement of Awards

Applicants will be notified of the outcome of awards by February 2023. Selected new investigators will receive an award agreement that must be signed and returned to AACP before funds are disbursed.

Conditions for Accepting the AACP NIA

In order to accept the AACP NIA, the recipient must agree the following conditions:

  1. The recipient will use the funds solely for the purposes that are stipulated in the original research application and are approved by AACP. None of the money awarded by the NIA can be used for any disallowed project costs such as the principal investigator’s salary or indirect costs. Research should begin promptly after the award is received. Unexpended funds must be returned at the end of the award period.
  2. The recipient will electronically submit an interim progress report at the end of six (6) months (by September 2023) and a final report at the end of funding period (no later than May 1, 2024). The final report will include the research findings as well as a financial statement as to how the grant was expended.    
  3. The recipient will present his or her final research findings from the NIA project as the primary presenting author at the 2023 AACP Annual Meeting. An additional travel award will be disbursed by AACP to defray travel expenses.
  4. The recipient will acknowledge funding support from the American Association of Colleges of Pharmacy in any publication, poster, or published abstract generated from the NIA project. Electronic copies of those publications, abstracts and posters should be submitted to AACP for record keeping.
  5. AACP must be notified when additional extramural funding is received within this funding period for the same project with overlapping research aims and budget.
  6. All NIA-funded research must be performed following all federal, state, and institutional guidelines established for Responsible Conduct of Research.

No-Cost Extensions

Request for a no-cost extension beyond the project end date must be made by e-mail to at least one month prior to its termination date. Requests will be carefully reviewed and determined on a case-by-case basis. 

Termination of the Award

Circumstances may arise necessitating the termination of the project prior to completion by either the institution or the investigator. This may be arranged at any time by agreement between the individual, the institution, and AACP. Termination will be made with the understanding that all unexpended funds will be returned to AACP, and that any unpaid balance of the award will be cancelled.

Return of Unused Funds

Awarded funds that are not used are to be returned to AACP. If the investigator changes faculty appointment between institutions, transfer of funds needs to take place between the previous institution and the new institution by filling out the NIA transfer of funds form.